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Abstract
Background: Colorectal cancer (CRC) represents a serious and growing health problem in Canada. Colonoscopy is
used for screening and diagnosis of symptomatic or high CRC risk individuals. Although a number of countries are
now implementing quality colonoscopy services, knowledge synthesis of barriers and facilitators perceived by
healthcare professionals and patients during implementation has not been carried out. In addition, the perspectives
of various stakeholders towards the implementation of quality colonoscopy services and the need of an efficient
organisation of such services have been reported in the literature but have not been synthesised yet. The present
study aims to produce a comprehensive synthesis of actual knowledge on the barriers and facilitators perceived by
all stakeholders to the implementation of quality colonoscopy services in Canada.
Methods: First, we will conduct a comprehensive review of the scientific literature and other published
documentation on the barriers and facilitators to implementing quality colonoscopy services. Standardised
literature searches and data extraction methods will be used. The quality of the studies and their relevance to
informing decisions on colonoscopy services implementation will be assessed. For each group of users identified,
barriers and facilitators will be categorised and compiled using narrative synthesis and meta-analytical techniques.
The principle factors identified for each group of users will then be validated for its applicability to various
Canadian contexts using the Delphi study method. Following this study, a set of strategies will be identified to
inform decision makers involved in the implementation of quality colonoscopy services across Canadian
jurisdictions.
Discussion: This study will be the first to systematically summarise the barriers and facilitators to implementation
of quality colonoscopy services perceived by different groups and to consider the local contexts in order to ensure
the applicability of this knowledge to the particular realities of various Canadian jurisdictions. Linkages with
strategic partners and decision makers in the realisation of this project will favour the utilisation of its results to
support strategies for implementing quality colonoscopy services and CRC screening programs in the Canadian
health system.
Background
Colorectal cancer (CRC) is currently seen as a serious
and growing public health problem in Canada [1]. CRC is
the third most common type of cancer in Canadian men
and women. In 2010, 9,100 persons are expected to die
from CRC, making it the second most lethal cancer for
Canadians [1]. Several randomised controlled trials have
supported the fact that screening with a faecal occult
blood test significantly reduces CRC-related mortality
[2,3], and many countries have implemented screening
programs using this test [4]. Moreover, a large, rando-
mised, controlled trial conducted in the United Kingdom
showed that one flexible sigmoidoscopy screen per-
formed between the ages of 55 and 64 years old can
reduce CRC incidence and mortality [5]. However, imple-
mentation technicalities are often hampering expected
screening benefits in many countries [6-8]. Recently, a
Canadian expert group investigated the suitability and
feasibility of a CRC screening program in Quebec [9].
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quality colonoscopy services, which must be on the top
of every screening program manager’s priority list. Com-
parable conclusions were achieved by a similar team in
New Zealand [10].
Colonoscopy is used for screening and diagnosis of
symptomatic or high CRC risk individuals [11-13]. This
test allows for direct visualisation of the entire colon, as
well as biopsies and excisions of lesions. Colonoscopy
requires expertise in order to efficiently identify lesions
and perform safe exams [14]. Two requirements are
essential to making a test of desired quality. Firstly, the
colonoscope must be introduced as far as the proximal
end of the colon (the caecum) to enable completeness
of the exam. Secondly, the retrieval speed of the colono-
scope must be sufficiently slow to allow thorough visual
examination of the colon and detection of lesions.
A study reported that neoplasia detection rises from
12% to 28% when retrieval time is above six minutes
[14]. In addition, a correlation between pace of retrieval
and the rate of detection of polyps has also been
reported [15,16]. Slowing the pace of retrieval is more
beneficial for the detection of small polyps, becoming
nonsignificant for polyps of 20 mm and more.
Although considered a standard of reference for ade-
nomas and cancer detection, colonoscopy is not a per-
fect procedure. Rex et al. evaluated the miss rate for
adenomas in 183 patients who had two consecutive
colonoscopies performed by two different physicians
during the same day [17]. The miss rate for adenomas
was 24% overall, 27% for adenomas less than 5 mm,
13% for adenomas ranging from 6 to 9 mm, and 6% for
adenomas of 1 cm and more. A Manitoba retrospective
study of 36,000 individuals without CRC after a colono-
scopy showed the limits of this method [18]. After five
years, the CRC incidence of this cohort was only 45%
lower than that of the general population of the pro-
vince. Moreover, colonoscopy is less effective for the
d e t e c t i o no fc a n c e ri nt h ep r o x i m a lc o l o nt h a ni nt h e
distal colon [19-21]. The reasons behind this difference
in performance are still ambiguous. Finally, it is worth-
while to mention that a risk of complications does exist,
and these complications might be as serious as haemor-
rhage, perforation, and even death [22-25]. Although
relatively rare, these complications can be of great con-
cern in the context of large-scale population screening.
Some interventions have proven effectiveness in redu-
cing the risk of colonoscopy complications. Korman and
colleagues investigated the rate of perforations in a very
large series (116,000) of colonoscopies performed on
outpatients in the United States [26]. All of the 45
clinics in this study where operating under the supervi-
sion of a quality assessment committee (QAC) that
reviewed all cases with complications and reported them
to a Medical Affairs’ Officer (MAO). A rate of 0.3 per-
forations per 1,000 tests was obtained, which is amongst
the lowest reported. This study shows that a low rate of
perforation is achievable when a large cohort of faecal
occult blood test-positive outpatients is being tested in a
screening program. A second study conducted in
Germany stressed the importance of the level of practice
for gastroenterologists [27]. The median number of
colonoscopies per physician was 772 (400 to 1200).
According to the authors, a high level of practice is
associated with a low rate of complications among
patients. The preceding two studies demonstrate that
CRC screenings of magnitude similar to what is
expected in Quebec are feasible and that low rates of
complications are also reachable. Although the actual
rate of complication in Quebec is unknown, it is unli-
kely that it is low on account of the lack of QACs
reporting to MAOs and the lack of iterative actions that
foster practice upgrading of physicians. Identifying and
indexing barriers and facilitators to auditing complica-
tions and the level of practice of physicians would facili-
tate implementation of quality colonoscopy services in
the healthcare system.
Endoscopist characteristics and the type of setting
where the colonoscopy is performed are also related to
the quality of this procedure. A population-based study
of 110,402 individuals aged 50 to 80 years old from
Ontario showed an association between incidence of
CRC after a negative colonoscopy and endoscopist spe-
ciality [28]. Those who had their colonoscopies per-
formed by a gastroenterologist had a reduced risk of
developing subsequent CRC. Bressler and colleagues
evaluated the rates of new and missed CRC after colo-
noscopy and their corresponding risk factors [29]. They
f o u n dt h a tp a t i e n t sw e r em o r el i k e l yt oh a v ean e wo r
missed CRC when their colonoscopies were performed
by family physicians and internists or in office-based
practices [29]. In addition, patients who had their colo-
n o s c o p yd o n ei nap r i v a t eo f f i c ew e r em o r el i k e l yt o
have an incomplete procedure compared with those
who had their colonoscopy done in an academic hospi-
tal [30]. Finally, endoscopist experience is associated
with the risk of complications [31]. Patients who had
their colonoscopy performed by a proficient endoscopist
h a dar e d u c e dr i s ko fb l e e d i n ga n dp e r f o r a t i o n .H o w -
ever, there is no evidence that endoscopist specialty is a
risk factor for colonoscopy-related complications [31].
Challenges to implementing a colorectal screening
program in a complex healthcare system
Introduction of CRC screening programs will lead to
increased demands for colonoscopy services such that,
unless resources are adequately planned, wait times for
colonoscopy may be prolonged. For instance, in
Jobin et al. Implementation Science 2010, 5:85
http://www.implementationscience.com/content/5/1/85
Page 2 of 9England [32,33] and Australia [34], where colonoscopy
services were used to respond timely to the demands,
it was impossible to respond adequately to the surge in
demands induced by screening. Several factors hamper
accurate estimation of Quebec’s healthcare system’s
ability to meet demands for colonoscopy services [9].
First, available procedures used for monitoring patients
and organising appointments are not well established.
Second, there are no systems to set priority for
demands in colonoscopy. According to the Canadian
Association of Gastroenterology, the median time for
having a colonoscopy in Quebec is 10 weeks, and 25%
of individuals will wait more than 21 weeks [35].
Moreover, 50% of all individuals presenting alarming
symptoms will wait more than 6.5 weeks, while
another 25% will only have access to a colonoscopy
after 16 weeks or more [35]. Therefore, it is certain
that Quebec’s healthcare system’s current ability to
meet demands for colonoscopy services is insufficient
[9,35]. The appropriateness of colonoscopy is also cru-
cial and must be taken into account when implement-
ing a CRC screening program [9]. Recently, a study
evaluated the appropriateness of colonoscopies per-
formed in several European countries and revealed
that only 46% are appropriate or necessary [36]. To
the best of our knowledge, no similar study has been
conducted in Quebec. Consequently, a significant pro-
portion of colonoscopies could be inappropriate, which
reduces Quebec’s healthcare system’sc a p a c i t yt o
respond to demands for colonoscopy services and
hampers subsequent implementation of a CRC screen-
ing program [9]. Nevertheless, it is worthwhile to men-
tion that some interventions, such as education
programs, have proven to be effective in reducing the
number of inappropriate colonoscopies [37].
It is mandatory to implement an effective and efficient
screening program in the healthcare system that is able
to reduce CRC incidence and mortality while ensuring a
low level of adverse effects [38,39]. In addition, such a
screening program must also be reasonable in terms of
costs, including medical costs and costs borne by
patients, such as time and effort [38]. In the current con-
text of scarce resources, it is a challenge to guarantee the
effective use of finite resources allocated to the healthcare
system while maintaining quality services [40].
Given the lack of current evidence on effective strategies
to implement quality colonoscopy services, there is an
urgent need to summarise present knowledge on barriers
and facilitators to the implementation of such services.
Patients and public participation in the implementation
of quality colonoscopy services
The public and patients have so far played a marginal
role in defining how clinical services could be
implemented and used [41]. Nevertheless, they are
increasingly calling for greater participation in decisions
regarding their health and the future of the healthcare
system [42,43]. This desire was recently echoed in a
pan-Canadian consultation of healthcare managers, deci-
sion makers, researchers, and stakeholders who identi-
fied public engagement as one of the key emerging
short- and long-term research priorities for the health-
care system [44].
Drolet and colleagues conducted a study to evaluate
Quebecers’ intention to participate in a CRC screening
program [45]. They found that 90% of individuals inter-
viewed will accept a colonoscopy diagnostic test if they
have a positive faecal occult blood test, which is a very
high proportion [45]. It is essential to highlight that the
preceding study evaluated the intention to have a colono-
scopy and not the proportion of individuals undergoing a
colonoscopy. In fact, studies that evaluated the participa-
tion rate in colonoscopy for CRC screening show low
levels of participation, even in high-risk individuals [46].
Therefore, taking into account the perspectives of patients
and the public in defining quality standards for colono-
scopy services appears essential to ensure that the services
reflect their values, needs, and preferences. Ultimately, it
could increase the participation rate for colonoscopy diag-
nostic tests and improve health outcomes. Citizens’ doubts
and concerns should be taken into account in order to
achieve the full benefits of healthcare services. In addition,
public and patient participation may enlighten us about a
number of issues raised by the implementation and use of
colonoscopy services, such as informed consent in light of
the potential risks and benefits [9].
Patient satisfaction is an important facet to quality
colonoscopy services. Considering that the majority of
individuals undergoing a screening colonoscopy will not
have CRC [47,48], it is important to ensure that the
patient’s experience of the colonoscopy is acceptable. On
the other hand, CRC screening involves surveillance of
those who are found to have adenomatous polyps, which
represents a large proportion of the eligible population
undergoing colonoscopy [49]. In those patients, repeated
colonoscopies are required at intervals typically ranging
between 3 to 10 years, according to their risk of subse-
quent advanced neoplasia [49]. The quality of the patient
experience has to be acceptable to ensure proper compli-
ance with surveillance guidelines. Aspects of patient-
centered colonoscopy care have been developed and
disseminated through the National Health Services’
Endoscopy Global Rating Scale [50]. This includes timely
access to colonoscopy, adequate communication about
the procedure, its risks and benefits, the preparation
involved for the test, appropriate demeanour of the
endoscopist and staff, and ability for patients to provide
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results and well-communicated plan of action [50].
A comprehensive and contextualised literature synth-
esis is necessary to better understand the needs of the
public and patients in pluralist health systems in order
to implement quality colonoscopy services.
Gaps in knowledge addressed by this proposal
Patients’ and healthcare professionals’ perspectives
towards the efficient implementation of quality colono-
scopy services have been reported in the literature
[41,50-52]. Although a number of countries are now
implementing quality colonoscopy services, a knowledge
synthesis of barriers and facilitators perceived by health-
care professionals and patients during implementation
has not been carried out [45,53]. In a healthcare system
that tends towards greater interdisciplinarity [54], it is
central to acknowledge the dynamics of each group of
users and their interdependence when implementing
quality colonoscopy services in a complex healthcare
setting.
This knowledge is also central to authorities who wish
to level implementation difficulties that could hamper
expected benefits from CRC screening. Evidence is
urgently needed to prepare for this major shift in our
healthcare system and to oversee the factors that could
affect its adoption and integration by all potential stake-
holders. This project aims at producing knowledge that
is relevant, timely, and useful for decision makers who
are directly responsible for the optimal implementation
of colonoscopy services in all Canadian jurisdictions.
Goal and objectives
This initiative aims to produce a comprehensive synthesis
of actual knowledge and lack thereof on the barriers and
facilitators influencing the implementation of quality
colonoscopy services. This knowledge will directly inform
decision makers on key issues that should be taken into
account for the implementation of such services. Our
objectives are to (1) conduct a mixed-methods review of
the literature on the barriers and facilitators related to
the implementation of quality colonoscopy services
among different stakeholders (gastroenterologists, sur-
geons, family physicians, nurses, decision-informants,
patients, healthcare services managers, healthcare sys-
tems administrators); (2) categorise, synthesise, and com-
pare the perceptions of these different groups; (3)
underline the adoption/acceptance factors specific to
each group and those specific to collective and interdisci-
plinary clinical work; and (4) identify strategic issues that
need to be addressed in the implementation of quality
colonoscopy services in the specific context of the Cana-
dian healthcare system.
Methods
The guiding principle of this knowledge synthesis is its
applicability to answering real challenges faced by deci-
sion makers in implementing a CRC screening program.
The project is divided into two main phases: reviewing
and synthesising relevant literature on barriers and facil-
itators perceived by all stakeholders to implementation
of quality colonoscopy services and validating these find-
ings in the context of the Canadian healthcare system
through a Delphi study.
Phase 1: systematic review of barriers and facilitators to
implementation of quality (clinical and patient
perspectives) colonoscopy services
In order to achieve objectives 1 and 2, we will conduct a
comprehensive review of the scientific literature (qualita-
tive, quantitative, and mixed-methods studies) and other
published documentation (technical or grey literature) on
the various factors that may have an impact on the qual-
ity of colonoscopy services. Among these factors, barriers
and facilitators to implementation of quality colonoscopy
services will be identified. Systematic reviews conducted
by the investigators [55,56] and other systematic reviews
in the field of healthcare CRC screening will guide the
development of search strategies.
Sources of data
Standardised literature searches will be performed on all
relevant databases (MEDLINE, Ovid, Cochrane Central
Register for Controlled Trials, Campbell Collaboration
Register for Controlled Trials, Current Content, Science
Citation Index, Social Sciences Citation Index, LISA,
CINAHL, PsycINFO, EMBASE, Electronics and Com-
munications Abstracts, Computer and Information Sys-
tems Abstracts, ERIC, ProQuest). The references of the
retrieved papers will be reviewed as a potential source
of further articles. Other literature will be identified
through internet search engines and governments’ web-
sites. Publications citing the selected articles as well as
other articles from authors of the selected articles will
be searched through the ISI Science Citation Index.
Finally, specialised email lists will be used to contact
experts in the field of CRC screening programs for
unpublished studies.
Inclusion/exclusion criteria
Types of studies
Studies must be based on a structured and well-described
data collection process; that is, research strategies and
measurement tools in relation to the study methodology
must be presented. Thus, studies reporting unstructured
observations, editorials, comments, or position papers
will be excluded. All rigorous quantitative, qualitative,
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scales will be used to assess the quality of each type of
design, based on a recent tool that proposes specific cri-
teria for assessing quantitative (experimental and obser-
vational), qualitative, and mixed-methods designs [57].
Systematic reviews and meta-analyses will be considered
if their main focus is related to barriers and facilitators to
implementation of quality colonoscopy services. Studies
published in all languages will be included as long as they
present an English abstract.
Stakeholders in quality colonoscopy services
Stakeholders are gastroenterologists, surgeons, family
physicians, nurses, decision-informants, patients, health-
care services managers, and healthcare system adminis-
trators, given that they are potentially among the most
involved in quality colonoscopy services in healthcare
systems [58]. We will consider studies investigating bar-
riers and facilitators to implementation of quality colo-
noscopy services from the perspectives of patients
having already undergone a colonoscopy, as well as the
perspectives of precolonoscopy patients. Studies focusing
on specific sociocultural groups will be excluded.
Intervention
Implementation of quality colonoscopy services will be
the targeted intervention. Quality of colonoscopy ser-
vices is defined as quality and safety (now called Clinical
Quality) or consumer care (now called Quality of
Patient Experience). We will consider implementation of
quality standards related to colonoscopy services.
Outcomes
Included studies must clearly mention factors that could
be considered to be barriers and/or facilitators to imple-
mentation of quality colonoscopy services, and they
must include a measurement of quality outcomes.
Screening and data abstraction
All titles and abstracts will be screened independently by a
team consisting of one of the two principal investigators
and a research associate to assess fitness of studies with
the inclusion criteria. Any discrepancies in study inclusion
between the two reviewers will be resolved by discussion
with other team members. After retrieval of full text copies
of relevant articles, each study will be independently evalu-
ated by two reviewers using specific exclusions and inclu-
sions criteria. For each included study, barriers and
facilitators will be categorised and compiled using a vali-
dated extraction grid. Stakeholders will be divided into
groups of users according to these results. The aforemen-
tioned extraction grid has been developed by one of the
investigator and combines various factors that are likely to
affect healthcare professionals’ behaviours identified from
existing conceptual frameworks [59,60]. It will be
customised to ensure its applicability to studies reporting
the perspectives of patients and citizens towards the
implementation of quality colonoscopy services.
Appraisal of study quality and relevance
The quality of all eligible studies will be assessed by two
independent reviewers using quality criteria specific to
quantitative, qualitative, and mixed-methods designs
[61-63]. Studies that fall below a quality threshold on
their respective quality scales will be discarded. Any dis-
crepancies in quality ratings will be resolved by discus-
sion and involvement of an arbitrator among other team
members if necessary. Studies will be ranked according
to their quality. Technical and grey literature will also
be appraised for quality, but given that there are no
known consensual quality criteria for this type of litera-
ture, studies from these sources will be considered to be
complementary to the scientific literature.
Methods for synthesising findings
Findings will be reported using consensual guidelines for
narrative syntheses and meta-analytical techniques
[60,64-66]. Factors identified will be grouped according
to the underlying theoretical concepts. An iterative analy-
tical method will be performed based on transparency
and consensus between the reviewers. Thus, other emer-
gent categories of barriers and facilitators might be added
to the classification grid during the review process.
A narrative synthesis [64,67] will be performed to sum-
marise the evidence from various types of studies accord-
ing to the quality ranking of studies previously
mentioned. A comparison of the barriers and facilitators
to implementation of quality colonoscopy services among
the various groups represented will be done using meta-
analytical techniques. Results will be presented according
to each user’s group and health consumers for which bar-
riers and facilitators have been studied. In addition, fac-
tors that are specific to interdisciplinary clinical work will
be clearly identified. This synthesis will provide insight
on a wide range of conditions that might influence the
acceptance, adoption, utilisation, and integration of qual-
ity colonoscopy services in the healthcare system.
Strategies to ensure methodological rigour
Guidelines from recognised organisations, such as the
Cochrane Collaboration, will be followed to ensure the
methodological rigour of this systematic review. Given
the variability in the nature of the literature that will be
assessed through this review, we will make sure that
appropriate criteria are used to assess the quality of
each type of study (quantitative, qualitative, and mixed-
methods).
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In the second phase of the study (five months), findings
from the systematic review of each group of users will
be validated for their applicability and their importance
to the Canadian context through a Delphi process,
involving representatives from each group of users.
A Delphi study is a technique that compares the degree
of written agreement among participants who are not in
c o n t a c ta ta n y t i m e[ 6 8 ] .I ti sc o n s i d e r e dt ob eas t r o n g
methodology for a rigorous consensus of users on a spe-
cific theme. This type of study is highly recommended
for obtaining opinions from users who live and work in
different geographic areas and settings [69], giving us
the opportunity to have a pan-Canadian representation.
The anonymity of the Delphi process also encourages
open and honest feedback among participants.
Selection and recruitment of the expert panel
The aim of the Delphi study is to obtain opinions from
each group of users representing a variety of expertises
and contexts in Canada. As such, 10 to 18 participants
[68] for each group of users will be recruited across
Canada through professional associations and corpora-
tions, regional health authorities, and experts from each
province concerned with the implementation of quality
colonoscopy services. A list of potential participants will
be created through the contacts network method [70],
with the help of decision makers of the team and their
collaborators. Recruitment of participants will be done
through a message sent by email. A postcard will also
be sent to allow for contacting participants who do not
have email or do not use it, to limit possible selection
bias. However, participants have to be able to access the
internet to be included in the study. The message will
present the study’s objectives, the nature of their impli-
cations, and will solicit their participation in the Delphi
study. The message will also provide a link to the study
website (or URL address in the postcard) and give parti-
cipants a temporary username. Participants will be
informed that their participation in the study is entirely
voluntary and that they implicitly consent to participate
when creating their electronic account.
The Delphi process
The first step of this Delphi study is to develop a pretest
questionnaire from the findings of the systematic review.
This questionnaire will focus on the main barriers and
facilitators that have been reported in the literature for
each group of users. The selection of items will be based
on their relative importance in the literature. In general,
items mentioned by 15% or more of the studies will be
kept, based on content-analysis techniques to identify
salient beliefs in the construction of questionnaires [71].
Our advisory committee, representing groups of users,
will face validate this questionnaire to ensure the good
understanding of the questions and to evaluate the time
needed to complete it. After this pretest, a final question-
naire will be prepared and made accessible electronically
on the secure website. All potential participants will be
sent by mail and email an information sheet about the
project, as well as a consent form. After creating their
personalized electronic accounts by entering their user-
names and choosing their passwords, participants will be
guided through the process of the electronic Delphi ques-
tionnaire. Participants will be asked to rate the applicabil-
ity and the importance of each proposed item on a seven-
point Likert scale. Results from the first round will be
compiled, and a mean score of applicability and impor-
tance for each item will be calculated. Then, participants
will be invited to partake in a second-round rating
process by email and postcard, through the password-
protected website [72,73]. Participants will again be asked
to rate the degree of applicability and importance of each
identified factor. This survey will also show the first-
round ratings by providing the mean score for each item.
Participants will also be able to add free text comments.
Email and postcard reminders will be sent to the partici-
pants after each round. A third-round survey, based on
the responses of the second round, might be necessary if
a consensus is not reached for at least 70% of items [74].
Finally, the consensual rating will be sent a last time to
the participants for a final validation.
Analysis of ratings
Aggregate ratings will be calculated and feedback com-
ments will be content analysed for each round of the
survey. In addition, to ensure equal weighting for each
user’s group in the overall rating, a weighted median
will be calculated. A satisfactory degree of consensus
will be obtained if less than 30% of the ratings are in
the lower range (ratings from 1 to 2) and less than
30% of the ratings are in the upper range (ratings from
6 to 7) [72,73,75].
Strategies to ensure methodological rigour in the Delphi
study
T h ec h o i c eo ft h ei t e m sf o rt h eD e l p h iq u e s t i o n n a i r e
will be based on rigorous content-analysis techniques
that identify salient beliefs through the number of times
mentioned by participants (15% and more will be kept)
[71]. In addition, the questionnaire will be face validated
by the advisory committee that represents groups of
users. Finally, to ensure that the panel of participants
represents specialists recognised by their peers, the
selection of experts will be done with the help of mem-
bers of the advisory committee who are in strategic
positions to give this information (healthcare profes-
sional associations and corporations). The invitation to
Jobin et al. Implementation Science 2010, 5:85
http://www.implementationscience.com/content/5/1/85
Page 6 of 9participate in the Delphi study will be sent to 30 partici-
pants of each group to ensure that at least 10 of them
will answer all the rounds of the study. These invitations
will be sent by mail and email to limit possible selection
bias by allowing for contacting participants who do not
have email or do not use it.
Ethical considerations
Exemption from ethics approval has been received from
the Research Ethics Board of the Centre Hospitalier
Universitaire de Québec Research Centre (11 August
2010; ethics number S10-09-067-AQEM). Participants to
the Delphi study will be sent emails presenting the
study’s objectives and information about research impli-
cations. They will be informed that their participation in
the study is entirely voluntary and that they implicitly
consent to participate when creating their electronic
account.
Discussion and implications
This study will produce a comprehensive synthesis of
actual knowledge on the barriers and facilitators per-
ceived by stakeholders to implementation of quality
colonoscopy services. Moreover, the Delphi study will
validate findings from the literature review, which con-
stitutes a novel approach that produces results that are
more attractive for decision makers and more directly
applicable to the elaboration of policies and strategies in
the Canadian context. The results of this study will be
particularly relevant, timely, and useful for decision
makers who currently face the challenge of implement-
ing quality colonoscopy services and CRC screening
programs in the healthcare system.
In addition, this project will favour partnerships
between researchers and direct stakeholders of research
results (strategic collaborators and decision makers) by
integrating them in all steps of the project and integrat-
ing their specific needs in the way that the knowledge is
synthesised, transferred, and applied. The participation
of strategic decision makers in the research team will
encourage knowledge sharing through their networks.
These sustained relationships between all members of
the team and collaborators will greatly contribute to the
relevance, uptake, and utilisation of the results to sup-
port an optimal implementation of quality colonoscopy
services in the Canadian healthcare system.
In conclusion, this study will be the first to systemati-
cally summarise the barriers and facilitators (clinical and
patients’ perspectives) to implementing quality colono-
scopy services perceived by different groups and to con-
sider the local contexts in order to ensure the applicability
of this knowledge to the particular realities of the various
Canadian jurisdictions. Linkages with strategic partners
and decision makers in the realisation of this project will
favour the utilisation of its results to support strategies
for implementing quality colonoscopy services in the
Canadian health system.
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